SCALVINI, Laura
 Distribuzione geografica
Continente #
EU - Europa 962
NA - Nord America 755
AS - Asia 209
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.928
Nazione #
US - Stati Uniti d'America 752
IT - Italia 388
IE - Irlanda 178
SE - Svezia 155
CN - Cina 146
AT - Austria 62
FI - Finlandia 50
DE - Germania 42
FR - Francia 28
TR - Turchia 23
VN - Vietnam 16
BE - Belgio 12
GB - Regno Unito 11
CZ - Repubblica Ceca 10
IN - India 8
SG - Singapore 8
ES - Italia 7
NL - Olanda 6
HK - Hong Kong 5
UA - Ucraina 4
CA - Canada 3
HR - Croazia 3
RO - Romania 3
JP - Giappone 2
A1 - Anonimo 1
EU - Europa 1
LU - Lussemburgo 1
NO - Norvegia 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 1.928
Città #
Chandler 200
Dublin 173
Parma 109
Ann Arbor 90
Ashburn 64
Vienna 59
Dearborn 32
Beijing 30
New York 28
Shanghai 28
Princeton 27
Wilmington 24
Bologna 21
Nanjing 19
Izmir 18
Dong Ket 16
Seattle 16
Bremen 15
Helsinki 14
Fremont 12
Los Angeles 12
Milan 12
Guangzhou 11
Prata Di Pordenone 11
Brussels 9
Modena 9
Nanchang 9
Ardea 8
Boardman 8
Brescia 8
Jinan 8
Des Moines 7
London 7
Piacenza 7
Shenyang 7
Brno 6
Düsseldorf 6
Rome 6
Canneto sull'Oglio 5
Fairfield 5
Hebei 5
Montegaldella 5
Norwalk 5
Paris 5
Pune 5
Verona 5
Ankara 4
Hong Kong 4
Kunming 4
Naples 4
San Mateo 4
Atlanta 3
Belluno 3
Braunschweig 3
Cesano Maderno 3
Changsha 3
Dueville 3
Ferrara 3
Fuzhou 3
Genoa 3
Jiaxing 3
Leuven 3
Padova 3
Solignano 3
Tianjin 3
Zagreb 3
Alessandria 2
Amsterdam 2
Bilbao 2
Borås 2
Caprino Veronese 2
Casalnuovo di Napoli 2
Castiglione Olona 2
Council Bluffs 2
Ferrara di Monte Baldo 2
Fidenza 2
Frankfurt am Main 2
Grafing 2
Houston 2
Lanzhou 2
Lübeck 2
Ospitaletto 2
Palermo 2
Pomigliano d'Arco 2
Quattro Castella 2
Redwood City 2
Reggio Emilia 2
Rende 2
Rocca Grimalda 2
Rockville 2
Romainville 2
Stockholm 2
Suzzara 2
Taranto 2
Tokyo 2
Urbino 2
Vignola 2
Woodbridge 2
Aulla 1
Baotou 1
Totale 1.317
Nome #
Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines 129
Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties 114
Drug-gut microbiota metabolic interactions: the case of UniPR1331, selective antagonist of the Eph-ephrin system, in mice 95
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 92
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment 84
Chiral Recognition of Flexible Melatonin Receptor Ligands Induced by Conformational Equilibria 83
N-Acylethanolamine Acid Amidase (NAAA): Structure, Function, and Inhibition 83
Free-Energy Simulations Support a Lipophilic Binding Route for Melatonin Receptors 80
Chapter 9: Natural and Synthetic Agents That Target Intracellular Monoacylglycerol Lipase (MGL) Activity 74
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine 68
Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists 67
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands 66
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids 66
N-Acylethanolamine Acid Amidase (NAAA): Mechanism of Palmitoylethanolamide Hydrolysis Revealed by Mechanistic Simulations 63
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 62
Identification of bivalent ligands with melatonin receptor agonist and fatty acid amide hydrolase (FAAH) inhibitory activity that exhibit ocular hypotensive effect in the rabbit 58
Monoglyceride lipase: Structure and inhibitors 49
Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents 49
Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity 48
Free-energy studies reveal a possible mechanism for oxidation-dependent inhibition of MGL 48
Design and SAR Analysis of Covalent Inhibitors Driven by Hybrid QM/MM Simulations 47
Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents 47
Different roles for the acyl chain and the amine leaving group in the substrate selectivity of N-Acylethanolamine acid amidase 45
Synthesis and characterization of new bivalent agents as melatonin- and histamine h3-ligands. 44
Fighting tertiary mutations in EGFR-driven lung-cancers: Current advances and future perspectives in medicinal chemistry 43
Repurposing of drugs targeting yap-tead functions 42
New classes of potent heparanase inhibitors from ligand-based virtual screening 42
Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency 38
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 37
New Coumarin derivatives as cholinergic and cannabinoid system modulators 32
Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity 26
In silico drug discovery of melatonin receptor ligands with therapeutic potential 20
Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library 20
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 16
Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations 14
Phenotype Screening of an Azole-bisindole Chemical Library Identifies URB1483 as a New Antileishmanial Agent Devoid of Toxicity on Human Cells 11
Totale 2.002
Categoria #
all - tutte 7.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 19 0
2019/2020155 28 7 0 2 13 28 13 4 9 42 7 2
2020/2021278 1 0 32 10 26 41 30 22 40 17 10 49
2021/2022240 11 15 12 35 37 4 20 19 22 7 9 49
2022/2023877 72 87 64 73 78 107 8 44 232 23 64 25
2023/2024333 33 22 24 18 33 77 27 53 21 21 4 0
Totale 2.002